NHS England updates CDF List

NHS England has upded the Cancer Drugs Fund List on its website. We have updated our website to correspond.

NHS England updates CDF List

NHS England has updated the Cancer Drugs Fund List. The latest version (v1.366) was uploaded to the NHS England Website on Thursday 12, June 2025.

The following changes have been introduced:

Belantamab mafadotin in combination with bortezomib and dexamethasone (BELA1)

Belantamab mafadotin in combination with bortezomib and dexamethasone as 2nd line treatment of relapsed or refractory myeloma in adult patients who previously received lenalidomide as part of 1st line systemic therapy where the following criteria have been met

Recommended for routine commissioning, receiving CDF interim funding